Cover Image
市場調查報告書

全球避孕 (避孕藥、避孕器) 市場:產業分析,規模,佔有率,成長率,趨勢,預測

Contraceptives Market (Product - Contraceptive Drugs and Contraceptive Devices ; Distribution Channel - Hospital Pharmacy, Independent Pharmacy, Online Platform, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 322867
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球避孕 (避孕藥、避孕器) 市場:產業分析,規模,佔有率,成長率,趨勢,預測 Contraceptives Market (Product - Contraceptive Drugs and Contraceptive Devices ; Distribution Channel - Hospital Pharmacy, Independent Pharmacy, Online Platform, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2017 - 2025
出版日期: 2017年09月27日 內容資訊: 英文 189 Pages
簡介

本報告提供全球避孕 (避孕藥、避孕器) 市場相關調查分析,產業分析,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統性資訊。

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 主要市場指標
  • 市場動態
  • 市場分析與預測
  • 供需方案
  • 波特的五力分析
  • 價值鏈分析
  • 市場預測

第5章 全球避孕市場分析與預測:各產品

  • 簡介、定義
  • 主要調查結果/發展
  • 主要趨勢
  • 市場價值預測
  • 市場魅力

第6章 全球避孕市場分析與預測:各銷售管道

  • 簡介、定義
  • 主要調查結果/發展
  • 主要趨勢
  • 市場價值預測
  • 市場魅力

第7章 全球避孕市場分析與預測:各地區

  • 主要調查結果
  • 政策和法規
  • 市場價值預測
  • 市場魅力

第8章 北美的避孕市場分析與預測

第9章 歐洲的避孕市場分析與預測

第10章 亞太地區的避孕市場分析與預測

第11章 南美的避孕市場分析與預測

第12章 中東、非洲的避孕市場分析與預測

第13章 競爭情形

  • 市場企業:競爭矩陣
  • 市場佔有率分析:各企業
  • 企業簡介
    • Merck & Co., Inc.
    • Cipla Inc.
    • Allergan plc
    • Bayer AG
    • HLL Lifecare Limited
    • Mankind Pharma
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd
    • Mithra Pharmaceuticals
    • Janssen Pharmaceutical Company
    • Reckitt Benckiser Group plc

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Contraceptives Market: Overview

The report on the contraceptive market analyzes the current and future scenario of the global market. Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.

The contraceptive market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global contraceptive market with respect to the segments based on product type, distribution channel and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter's five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.

Global Contraceptives Market: Market Segmentation

Based on product type, the contraceptive market is segmented as contraceptives drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptive is segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been analyzed based on available drugs and devices, product pipeline for new contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been extensively analyzed based on availability of different contraceptive products, availability of these products at different distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global contraceptive market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Global Contraceptives Market: Competitive Landscape

The report also profiles major players in the global contraceptive market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck & Co., Inc., Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.

The Global Contraceptives Market is segmented as given below:

  • Global Contraceptives Market, by Product
  • Contraceptive Drugs
  • Oral Contraceptives
  • Combined Contraceptives
  • Mini-pills
  • Contraceptive Injectable
  • Topical Contraceptive Patch
  • Contraceptive Devices
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Female Condoms
  • Contraceptive Diaphragms
  • Contraceptive Sponges
  • Contraceptive Vaginal Rings
  • Intrauterine Devices
  • Sub-dermal Contraceptives Implants
  • Non-Surgical Permanent Contraception Devices
  • Global Contraceptives Market, by Distribution Channel
  • Hospitals Pharmacy
  • Public
  • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others
  • Global Contraceptive Market, by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • U.K.
  • Russia
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • India
  • China
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Contraceptive Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Contraceptive Market Analysis and Forecasts, 2015-2025
    • 4.5.1. Market Revenue Projections (US$ Mn)
  • 4.6. Contraceptive Market - Global Supply Demand Scenario
  • 4.7. Porter's Five Force Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Market Outlook

5. Global Contraceptive Market Analysis and Forecasts, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast By Product , 2015-2025
    • 5.4.1. Contraceptive Drugs
      • 5.4.1.1. Oral Contraceptives
        • 5.4.1.1.1. Combined Contraceptives
        • 5.4.1.1.2. Mini-pills
      • 5.4.1.2. Contraceptive Injectable
      • 5.4.1.3. Topical Contraceptive Patch
    • 5.4.2. Contraceptive Devices
      • 5.4.2.1. Male Contraceptive Devices
      • 5.4.2.2. Female Contraceptive Devices
        • 5.4.2.2.1. Female Condoms
        • 5.4.2.2.2. Contraceptive Diaphragms
        • 5.4.2.2.3. Contraceptive Sponges
        • 5.4.2.2.4. Contraceptive Vaginal Rings
        • 5.4.2.2.5. Intrauterine Devices
        • 5.4.2.2.6. Sub-dermal Contraceptives Implants
        • 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
  • 5.5. Market Attractiveness By Product

6. Global Contraceptive Market Analysis and Forecasts, By Distribution Channel

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast By Distribution Channel, 2015-2025
    • 6.4.1. Hospital Pharmacy
      • 6.4.1.1. Public
      • 6.4.1.2. Private
    • 6.4.2. Independent Pharmacy
    • 6.4.3. Online Platform
    • 6.4.4. Clinics
    • 6.4.5. Others
  • 6.5. Market Attractiveness By Distribution Channel

7. Global Contraceptive Market Analysis and Forecasts, By Region

  • 7.1. Key Findings
  • 7.2. Policies and Regulations
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness By Country/Region

8. North America Contraceptive Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
    • 8.1.2. Policies and Regulations
    • 8.1.3. Key Trends
  • 8.2. Market Value Forecast By Product, 2015-2025
    • 8.2.1. Contraceptive Drugs
      • 8.2.1.1. Oral Contraceptives
        • 8.2.1.1.1. Combined Contraceptives
        • 8.2.1.1.2. Mini-pills
      • 8.2.1.2. Contraceptive Injectable
      • 8.2.1.3. Topical Contraceptive Patch
    • 8.2.2. Contraceptive Devices
      • 8.2.2.1. Male Contraceptive Devices
      • 8.2.2.2. Female Contraceptive Devices
        • 8.2.2.2.1. Female Condoms
        • 8.2.2.2.2. Contraceptive Diaphragms
        • 8.2.2.2.3. Contraceptive Sponges
        • 8.2.2.2.4. Contraceptive Vaginal Rings
        • 8.2.2.2.5. Intrauterine Devices
        • 8.2.2.2.6. Sub-dermal Contraceptives Implants
        • 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 8.3. Market Value Forecast By Distribution Channel, 2015-2025
    • 8.3.1. Hospital Pharmacy
      • 8.3.1.1. Public
      • 8.3.1.2. Private
    • 8.3.2. Independent Pharmacy
    • 8.3.3. Online Platform
    • 8.3.4. Clinics
    • 8.3.5.Others
  • 8.4. Market Value Forecast By Country, 2015-2025
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By Distribution Channel
    • 8.5.3. By Country

9. Europe Contraceptive Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Policies and Regulations
    • 9.1.3. Key Trends
  • 9.2. Market Value Forecast By Product, 2015-2025
    • 9.2.1. Contraceptive Drugs
      • 9.2.1.1. Oral Contraceptives
        • 9.2.1.1.1. Combined Contraceptives
        • 9.2.1.1.2. Mini-pills
      • 9.2.1.2. Contraceptive Injectable
      • 9.2.1.3. Topical Contraceptive Patch
    • 9.2.2. Contraceptive Devices
      • 9.2.2.1. Male Contraceptive Devices
      • 9.2.2.2. Female Contraceptive Devices
        • 9.2.2.2.1. Female Condoms
        • 9.2.2.2.2. Contraceptive Diaphragms
        • 9.2.2.2.3. Contraceptive Sponges
        • 9.2.2.2.4. Contraceptive Vaginal Rings
        • 9.2.2.2.5. Intrauterine Devices
        • 9.2.2.2.6. Sub-dermal Contraceptives Implants
        • 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 9.3. Market Value Forecast By Distribution Channel, 2015-2025
    • 9.3.1. Hospital Pharmacy
      • 9.3.1.1. Public
      • 9.3.1.2. Private
    • 9.3.2. Independent Pharmacy
    • 9.3.3. Online Platform
    • 9.3.4. Clinics
    • 9.3.5. Others
  • 9.4. Market Value Forecast By Country, 2015-2025
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. U.K.
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Distribution Channel
    • 9.5.4. By Country

10. Asia Pacific Contraceptive Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Policies and Regulations
    • 10.1.3. Key Trends
  • 10.2. Market Value Forecast By Product, 2015-2025
    • 10.2.1. Contraceptive Drugs
      • 10.2.1.1. Oral Contraceptives
        • 10.2.1.1.1. Combined Contraceptives
        • 10.2.1.1.2. Mini-pills
      • 10.2.1.2. Contraceptive Injectable
      • 10.2.1.3. Topical Contraceptive Patch
    • 10.2.2. Contraceptive Devices
      • 10.2.2.1. Male Contraceptive Devices
      • 10.2.2.2. Female Contraceptive Devices
        • 10.2.2.2.1. Female Condoms
        • 10.2.2.2.2. Contraceptive Diaphragms
        • 10.2.2.2.3. Contraceptive Sponges
        • 10.2.2.2.4. Contraceptive Vaginal Rings
        • 10.2.2.2.5. Intrauterine Devices
        • 10.2.2.2.6. Sub-dermal Contraceptives Implants
        • 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 10.3. Market Value Forecast By Distribution Channel, 2015-2025
    • 10.3.1. Hospital Pharmacy
      • 10.3.1.1 Public
      • 10.3.1.2. Private
    • 10.3.2. Independent Pharmacy
    • 10.3.3. Online Platforms
    • 10.3.4. Clinics
    • 10.3.5. Others
  • 10.4. Market Value Forecast By Country, 2015-2025
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country

11. Latin America Contraceptive Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Policies and Regulations
    • 11.1.3. Key Trends
  • 11.2. Market Value Forecast By Product , 2015-2025
    • 11.2.1. Contraceptive Drugs
      • 11.2.1.1. Oral Contraceptives
        • 11.2.1.1.1. Combined Contraceptives
        • 11.2.1.1.2. Mini-pills
      • 11.2.1.2. Contraceptive Injectable
      • 11.2.1.3. Topical Contraceptive Patch
    • 11.2.2. Contraceptive Devices
      • 11.2.2.1. Male Contraceptive Devices
      • 11.2.2.2. Female Contraceptive Devices
        • 11.2.2.2.1. Female Condoms
        • 11.2.2.2.2. Contraceptive Diaphragms
        • 11.2.2.2.3. Contraceptive Sponges
        • 11.2.2.2.4. Contraceptive Vaginal Rings
        • 11.2.2.2.5. Intrauterine Devices
        • 11.2.2.2.6. Sub-dermal Contraceptives Implants
        • 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 11.3. Market Value Forecast By Distribution Channel, 2015-2025
    • 11.3.1. Hospital Pharmacy
      • 11.3.1.1. Public
      • 11.3.1.2. Private
    • 11.3.2. Independent Pharmacy
    • 11.3.3. Online Platforms
    • 11.3.4. Clinics
    • 11.3.5. Others
  • 11.4. Market Value Forecast By Country, 2015-2025
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Distribution Channel
    • 11.5.4. By Country

12. Middle East and Africa Contraceptive Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Policies and Regulations
    • 12.1.3. Key Trends
  • 12.2. Market Value Forecast By Product, 2015-2025
    • 12.2.1. Contraceptive Drugs
      • 12.2.1.1. Oral Contraceptives
        • 12.2.1.1.1. Combined Contraceptives
        • 12.2.1.1.2. Mini-pills
      • 12.2.1.2. Contraceptive Injectable
      • 12.2.1.3. Topical Contraceptive Patch
    • 12.2.2. Contraceptive Devices
      • 12.2.2.1. Male Contraceptive Devices
      • 12.2.2.2. Female Contraceptive Devices
        • 12.2.2.2.1. Female Condoms
        • 12.2.2.2.2. Contraceptive Diaphragms
        • 12.2.2.2.3. Contraceptive Sponges
        • 12.2.2.2.4. Contraceptive Vaginal Rings
        • 12.2.2.2.5. Intrauterine Devices
        • 12.2.2.2.6. Sub-dermal Contraceptives Implants
        • 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 12.3. Market Value Forecast By End User , 2015-2025
    • 12.3.1. Hospital Pharmacy
      • 12.3.1.1. Public
      • 12.3.1.2. Private
    • 12.3.2. Independent Pharmacy
    • 12.3.3. Online Platform
    • 12.3.4. Clinics
    • 12.3.5. Others
  • 12.4. Market Value Forecast By Country , 2015-2025
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East and Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Market Share Analysis By Company (2016)
  • 13.3. Company Profiles
    • 13.3.1. Merck & Co., Inc.
      • 13.4.1.1. Overview
      • 13.4.1.2. Financials
      • 13.4.1.3. Recent Developments
      • 13.4.1.4. Strategy
    • 13.3.2. Cipla Inc.
      • 13.4.2.1. Overview
      • 13.4.2.2. Financials
      • 13.4.2.3. Recent Developments
      • 13.4.2.4. Strategy
    • 13.3.3. Allergan plc
      • 13.4.3.1. Overview
      • 13.4.3.2. Financials
      • 13.4.3.3. Recent Developments
      • 13.4.3.4. Strategy
    • 13.3.4. Bayer AG
      • 13.4.4.1. Overview
      • 13.4.4.2. Financials
      • 13.4.4.3. Recent Developments
      • 13.4.4.4. Strategy
    • 13.3.5. HLL Lifecare Limited
      • 13.4.5.1. Overview
      • 13.4.5.2. Financials
      • 13.4.5.3. Recent Developments
      • 13.4.5.4. Strategy
    • 13.3.6. Mankind Pharma
      • 13.4.6.1. Overview
      • 13.4.6.2. Financials
      • 13.4.6.3. Recent Developments
      • 13.4.6.4. Strategy
    • 13.3.7. Pfizer, Inc.
      • 13.4.7.1. Overview
      • 13.4.7.2. Financials
      • 13.4.7.3. Recent Developments
      • 13.4.7.4. Strategy
    • 13.3.8. Teva Pharmaceutical Industries Ltd
      • 13.4.8.1. Overview
      • 13.4.8.2. Financials
      • 13.4.8.3. Recent Developments
      • 13.4.8.4. Strategy
    • 13.3.9. Mithra Pharmaceuticals
      • 13.4.9.1. Overview
      • 13.4.9.2. Financials
      • 13.4.9.3. Recent Developments
      • 13.4.9.4. Strategy
    • 13.3.10. Janssen Pharmaceutical Company
      • 13.4.10.1. Overview
      • 13.4.10.2. Financials
      • 13.4.10.3. Recent Developments
      • 13.4.10.4. Strategy
    • 13.3.11. Reckitt Benckiser Group plc
      • 13.4.11.1. Overview
      • 13.4.11.2. Financials
      • 13.4.11.3. Recent Developments
      • 13.4.11.4. Strategy

List of Tables

  • Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025
  • Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025
  • Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025
  • Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025
  • Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025
  • Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015-2025
  • Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015-2025
  • Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015-2025
  • Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015-2025
  • Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015-2025

List of Figures

  • Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 02: Global Contraceptives Market Value Share, by Product (2016)
  • Figure 03: Global Contraceptives Market Value Share, by Distribution Channel (2016)
  • Figure 04: Global Contraceptives Market Value Share, by Region (2016)
  • Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2025
  • Figure 06: Global Contraceptives Market Attractiveness, by Product Type, 2017-2025
  • Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2025
  • Figure 08: Global Contraceptives Market Attractiveness, by Contraceptive Drugs, 2017-2025
  • Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2025
  • Figure 10: Global Contraceptives Market Attractiveness, by Oral Contraceptives, 2017-2025
  • Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2025
  • Figure 12: Global Contraceptives Market Attractiveness, by Contraceptive Devices, 2017-2025
  • Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2025
  • Figure 14: Global Contraceptives Market Attractiveness, by Female Contraceptive Devices, 2017-2025
  • Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2015-2025
  • Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2015-2025
  • Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 18: Global Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2015-2025
  • Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2015-2025
  • Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2015-2025
  • Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2015-2025
  • Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015-2025
  • Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2025
  • Figure 25: Global Contraceptives Market Attractiveness, by Region, 2017-2025
  • Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 27: North America Contraceptives Market Attractiveness, by Country 2017-2025
  • Figure 28: North America Contraceptive Market Value Share, by Country, 2017 and 2025
  • Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2025
  • Figure 30: North America Contraceptives Market Attractiveness, by Product Type, 2017-2025
  • Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 32: North America Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 34: Europe Contraceptives Market Attractiveness, by Country, 2017-2025
  • Figure 35: Europe Contraceptive Market Value Share, by Country, 2017 and 2025
  • Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2025
  • Figure 37: Europe Contraceptives Market Attractiveness, by Product, 2017-2025
  • Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 39: Europe Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 41: Asia Pacific Contraceptives Market Attractiveness, by Country 2017-2025
  • Figure 42: Asia Pacific Contraceptives Market Value Share, by Country, 2017 and 2025
  • Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2025
  • Figure 44: Asia Pacific Contraceptives Market Attractiveness, by Product Type, 2017-2025
  • Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 46: Asia Pacific Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 48: Latin America Contraceptives Market Attractiveness, by Country 2017-2025
  • Figure 49: Latin America Contraceptives Market Value Share, by Country, 2017 and 2025
  • Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2025
  • Figure 51: Latin America Contraceptives Market Attractiveness, by Product Type, 2017-2025
  • Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 53: Latin America Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 55: Middle East & Africa Contraceptives Market Attractiveness, by Country 2017-2025
  • Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country, 2017 and 2025
  • Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2025
  • Figure 58: Middle East & Africa Contraceptives Market Attractiveness, by Product Type, 2017-2025
  • Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 60: Middle East & Africa Contraceptives Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 61: Global Contraceptives Drugs Market Share, by Company, 2016
  • Figure 62: Global Contraceptives Devices Market Share, by Company, 2016
Back to Top